Navigation Links
Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
Date:2/1/2012

across challenging lesions and reduce balloon growth during inflation to facilitate high-pressure stent deployment.  The everolimus drug and fluorinated copolymer used on the PROMUS Element Stent have been studied in multiple randomized clinical trials and 'real-world' registries, demonstrating excellent long-term safety and efficacy.

"We are proud to introduce the PROMUS Element Plus Stent System to physicians and patients in Europe and other CE Mark countries," said Michael Onuscheck, President, Europe, Middle East and Africa at Boston Scientific.  "It is the latest example of Boston Scientific's commitment to market leadership and continued innovation in drug-eluting stents."

The Company received CE Mark approval for the PROMUS Element Stent System in 2009 and for the PROMUS Element Plus Stent System in 2011.  In the U.S., the PROMUS Element Plus Stent System was approved by the Food and Drug Administration (FDA) in 2011.  The TAXUS® Element Paclitaxel-Eluting Stent System received CE Mark approval in 2010 and is commercialized in the U.S. as the ION™ Paclitaxel-Eluting Stent System, where it received FDA approval in 2011.About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Boston IVF Pioneers Worlds First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests
2. Boston Scientific Announces Favorable Ruling in Patent Infringement Case
3. Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial
4. nContacts Cardiac Ablation Technology to be Presented in Two Noteworthy Posters at Boston Atrial Fibrillation Symposium 2012
5. Boston Scientific Raises Awareness of Heart Disease at Brandon Jennings Invitational
6. Boston Scientifics Alair® Bronchial Thermoplasty System Achieves Important Reimbursement Milestones
7. Boston Scientific to Participate in 30th Annual J.P. Morgan Healthcare Conference
8. Boston Scientific Launches Charger™ PTA Balloon Catheter
9. Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus™ Spinal Cord Stimulator System
10. Boston Scientific Introduces Industry-Leading ICD and CRT-D Device Warranties
11. Boston Scientifics WATCHMAN® Device Implanted in First Patients in Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  B. Braun ... clinician and environmental safety with products, services and ... will feature its innovative Outlook® 400ES and Space ... barcoding capabilities at the American Association of Critical-Care ... the Boston Convention Center. ...
(Date:5/20/2013)... Mass. , May 20, 2013 ... ("OSI")  whose subsidiary companies include OMNIlife science®, Inc., Enztec, ... directors to their Board.  Guy Mayer ... as the Chairman of the Board of Directors ... join as a director. Before joining ...
(Date:5/20/2013)... ALEXANDRIA, Va. , May 20, 2013   ... B. Douglas Hoey , RPh, MBA issued the ... Hart Research Associates regarding Medicare Part D "preferred ... pharmacies from offering patients the plan,s lowest advertised co-payments: ... "Officials with Medicare and MedPAC , ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4
... Inc. (NYSE: HRC ) will release its fiscal ... company will host a webcast the following morning on Thursday, ... Earnings Release:   Hill-Rom,s Fiscal 2011 Third Quarter Earnings Release ... to the public after the close of the NYSE on ...
... N.J., June 29, 2011 Par Pharmaceutical Companies, Inc. ... of its branded division, Strativa Pharmaceuticals, as part of ... a workforce reduction of approximately 100.  The Company believes ... the near term. Patrick G. LePore, Chairman, ...
Cached Medicine Technology:Hill-Rom Holdings, Inc. Hosts Fiscal 2011 Third Quarter Earnings Webcast 2Par Pharmaceutical Companies Announces a Restructuring of Its Branded Division, Strativa Pharmaceuticals, to Maximize Profitability 2
(Date:5/21/2013)... Healthcare Solutions, the parent company of ... that it was honored to receive the Catamaran ... Conferred annually, the Innovation Award recognizes a client ... edge programs that improves cost and/or quality outcomes. ... its clinical and IT solutions that have helped ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The producers of ... May air dates for Peterborough, Ontario, Canada. The area is ... spot for Canadians and Americans. It is located an hour ... rivers. Peterborough is located in the Kawartha Hills, home to ... adds economic stability to the area. Residents and visitors to ...
(Date:5/21/2013)... 21, 2013 It’s nearly summer and millions ... or starting practice for summer or fall sports. In ... sporting activities can begin. , To help parents during ... youth sports or camp physicals at just $29. ... review a child’s medical history, perform a physical exam and ...
(Date:5/21/2013)... 21, 2013 Dallas-based TopMD™ Skin Care ... article testing the efficacy of their flagship product, ... clinical study results appear in the May/June 2013 issue ... “A Novel Sodium Hypochlorite Cleanser Shows Clinical Response and ... impressive findings seen after consistent use of the product ...
(Date:5/21/2013)... 2013 Dimensional Insight, a developer of ... Western Maryland Health System, a 275-bed hospital ... Solution™ (Diver) to help it analyze its data more ... to purchase Diver through Dimensional Insight’s recently announced ... hospitals, Western Maryland has massive amounts of data in ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3
... 3 Targeted Genetics Corporation,(Nasdaq: TGEN ) ... (NIH),Recombinant DNA Advisory Committee,s (RAC) assessment of the ... Phase I/II trial of,tgAAC94 for inflammatory arthritis., ... was a result of,complications from an opportunistic infection, ...
... ALBANY, N.Y., Dec. 3 AARP recently ... the state to,address three major issues that impact ... New Yorkers: prescription drug marketing reform and,affordability, housing ... are critical issues that help New Yorkers stay ...
... Dec. 3 Coherent, Inc.,(Nasdaq: COHR ) today ... of the Board of Directors of The Nasdaq Stock ... file its past due periodic reports,for the year ended ... 2007 with the Securities Exchange Commission ("SEC") in order ...
... ORLANDO, Fla., Dec. 3 A new study ... depressant effects in,patients (40 years and older) with ... measured by oxygenation or abnormal breathing,events relative to ... at the 53rd International,Respiratory Congress of the American ...
... that protect cells from the powerful, common chemotherapeutic agent ... how the drug also can destroy the heart., We ... for cell survival in the face of doxorubicin, says ... of Georgia Cancer Center. At the moment you start ...
... to lead can hinder the brains ability to recover ... The results have implications for the effects of environmental ... researchers at Jefferson Medical College, who led the work. ... increase the risk for cancer, renal disease, hypertension and ...
Cached Medicine News:Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 2Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 3Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 4Health News:AARP Urges Governor to Use Budget to Improve New Yorkers' Quality of Life 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 2Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 4Health News:Genes identified that protect against heart damage from chemotherapy 2Health News:Jefferson neuroscientists find early lead exposure impedes recovery from brain injury 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: